Semaglutide (Wegovy) is FDA-approved for chronic weight management (with criteria) and has strong clinical trial evidence for meaningful average weight loss when paired with lifestyle support
If you have risk factors or these symptoms, your doctor may recommend testing for vitamin B12 deficiency
(2021) showed that the GLP-1 RA drug class may be associated with a relative risk reduction for clinical kidney outcomes of 21% (HR 0.79
Tell your healthcare provider if you have changes in vision during treatment with Wegovy increased heart rate
We serve patients from Laurel MD , Maryland City MD, South Laurel MD, Ammendale MD, Savage MD, Annandale VA , Lincolnia VA, Alexandria VA, Lake Barcroft VA, North Springfield VA, Honolulu HI , Sand Island HI, Ala Moana HI, Palama HI, Moiliili HI, and surrounding areas
Are there specific clinical characteristics associated with the response of combined therapy with GLP1-RAs and SGLT2is